* Co-Diagnostics Inc CODX.OQ CODX.O is expected to show
a fall
in quarterly revenue when it reports results on August 10.
* The Salt Lake City Utah-based company is expected to
report a
90.0% decrease in revenue to $500 thousand from $5.02 million a
year ago, according to the estimate from one analyst, based on
Refinitiv data.
* Refinitiv's mean analyst estimate for Co-Diagnostics Inc
is for
a loss of 24 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for
Co-Diagnostics
Inc is $3.5, above its last closing price of $1.37.
This summary was machine generated August 9 at 02:01 GMT. All
figures in US dollars unless otherwise stated